Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Data and image processing

a) Quantification of three-dimensional PET data sets using compartment and non-compartment models

Dynamic PET data sets are evaluated and evaluated with regard to the diagnostic and prognostic value with different compartment and non-compartment models developed and implemented in the department. Compartment models are derived from pharmacology and have been used for the first time for PET studies in the brain to assess the pharmacokinetic behavior of fluorodeoxyglucose (FDG). We have used a modified two-compartment model with an additional blood compartment for oncologic patients for the first time. The model allows the calculation of so-called transport rates (k1, k2, k3, k4) and the exchange surface, the so-called distribution volume VB. In the example of FDG, k1 refers to the influx rate of FDG, k2 to the efflux rate, k3 to the phosphorylation, and k4 to the dephosphorylation.

b) Parametric imaging

Fig. 10a

Nuclear medicine images are functional images that reflect the mean activity distribution at a defined time. With the help of mathematical models it is possible to visualize an isolated parameter.

The following figure shows an FDG-PET cross-sectional view in a small pelvis in a patient with ovarian carcinoma and a suspected recurrence. Circumscribed FDG accumulation dorsal of the bladder, which indicates a tumor recurrence.

Fig. 10b

Such images are called parametric images. It is for example possible by means of a regression model, to represent only the perfusion-dependent part of a dynamic measurement with FDG in a tumorous lesion.

A parametric image showing the phosphorylated part of FDG. Due to the higher contrast the delineation of the lesion is better. This was an operative confirmed tumor recurrence.

c) Software fusion

In addition to the combined PET-CT or SPECT-CT devices, the so-called hybrid devices, it is possible to fuse arbitrary tomographic modalities by means of suitable evaluation programs. For this purpose, certain algorithms are used. We use the mutual information technology for the fusion of PET with CT or MRT recordings.


Fig. 11: Central tumor in the left lung with subsequent partial collapse of the lung. The mutual information technology allows the fusion of arbitrary modalities.
Above: Fusion of parametric PET images of the metabolism of FDG (color) and the blood volume (gray)
Center: Fusion of the parametric PET metabolism (color) with a corresponding CT image (gray)
Below: Fusion of the parametric PET metabolism (color) with a corresponding MRI image (gray)

d) GenePET

Tracer kinetics in PET are closely associated with molecular biology. If tissue samples from the PET-evaluated areas exist, PET and gene expression data can be evaluated correlatively. In this way it is possible to detect dependencies of the tracer kinetics on genes as well as to determine which genes modulate the kinetics (e.g., hypoxia and FDG kinetics). Furthermore, the gene expression data allow the search for new targets for potential radiopharmaceuticals.


Fig. 12: Correlative analysis of gene array data of a tissue sample of a tumor (left) and the corresponding PET results (right). The gene expression data are color coded as an image and thus allow a fast detection of genes, which are expressed significantly increased.

to top
powered by webEdition CMS